These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23334144)

  • 21. Brain metastases in patient with prostate cancer found in 18F-choline PET/CT.
    Gizewska A; Witkowska-Patena E; Stembrowicz-Nowakowska Z; Buraczewska A; Dziuk M
    Nucl Med Rev Cent East Eur; 2015; 18(1):39-41. PubMed ID: 25633517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
    Dejust S; Messaoud L; Jallerat P; Marical V; Morland D
    Clin Nucl Med; 2018 Oct; 43(10):780-781. PubMed ID: 30153155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT.
    Treglia G; Oragano L; Fadda G; Raffaelli M; Lombardi CP; Castaldi P; Rufini V
    Clin Nucl Med; 2014 May; 39(5):475-7. PubMed ID: 23640229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
    Kwee SA; Coel MN; Lim J; Ko JP
    J Urol; 2005 Jan; 173(1):252-5. PubMed ID: 15592091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
    García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
    Khor LK; Loi HY; Sinha AK; Lu SJ
    Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A thyroid incidentaloma detected by 18F-choline PET/CT.
    Treglia G; Giovannini E; Mirk P; Di Franco D; Oragano L; Bertagna F
    Clin Nucl Med; 2014 Apr; 39(4):e267-9. PubMed ID: 23579984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Rager O; Baskin A; Amzalag G; Buchegger F; Miralbell R; Ratib O; Zilli T; Garibotto V
    Nuklearmedizin; 2015; 54(5):211-6. PubMed ID: 26213186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markedly increased 18F-FDG uptake in a nonfunctioning adrenal adenoma mimicking malignancy.
    Treglia G; Oragano L; Fadda G; De Gaetano AM; Raffaelli M; Rufini V
    Clin Nucl Med; 2013 Aug; 38(8):e333-5. PubMed ID: 23486332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
    Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
    [No Abstract]   [Full Text] [Related]  

  • 31. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
    Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
    Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
    BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.
    Kwee SA; Thibault GP; Stack RS; Coel MN; Furusato B; Sesterhenn IA
    Mol Imaging; 2008; 7(1):12-20. PubMed ID: 18384719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
    Kwee SA; Coel MN; Ly BH; Lim J
    Ann Nucl Med; 2009 Aug; 23(6):541-8. PubMed ID: 19529978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
    Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
    Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.
    Hausmann D; Bittencourt LK; Attenberger UI; Sertdemir M; Weidner A; Büsing KA; Brade J; Wenz F; Schoenberg SO; Dinter DJ
    Clin Nucl Med; 2014 Mar; 39(3):e197-201. PubMed ID: 24092230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT.
    Kwee SA; Coel MN
    Clin Nucl Med; 2010 Feb; 35(2):128-9. PubMed ID: 20090467
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
    Calabria F; Chiaravalloti A; Tavolozza M; Ragano-Caracciolo C; Schillaci O
    Nucl Med Commun; 2013 Aug; 34(8):733-40. PubMed ID: 23680652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.